Indications and uses
temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold helps to loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes
temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold helps to loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes
do not take more than 6 doses in any 24-hour period measure only with dosing cup provided ml=milliliter this adult product is not intended for use in children under 12 years of age Age Dose Adults and children 12 years and over 5 mL every 4 hours Children under 12 years do not use
Store at 20°-25°C (68° -77°F). Do not refrigerate. Retain carton for future reference on full labeling
Dextromethorphan HBr USP 20 mg............. Cough suppressant
Guaifenesin, USP 300 mg............................... Expectorant
Relieves:
• Chest congestion / Mucus
• Cough
Stop use and ask a doctor ifcough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.
If pregnant or breast-feedingask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Age | Dose |
Adults and children 12 years and over | 5 mL every 4 hours |
Children under 12 years | do not use |
citric acid, flavor, glycerin, menthol, polyethylene glycol, propylene glycol, purified water, sodium benzoate, sodium saccharin, sorbitol.
Questions or comments?
Call 619-600-5632
Tamper evident: Do not use if inner seal under cap is broken or missing.
Exclusively distributed by
OPMX
Chula Vista, CA91910
Phone: 619-600-5632
Manufactured in
FDA Registered Facility
In the USA
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1117394 | dextromethorphan HBr 20 MG / guaiFENesin 300 MG in 5 mL Oral Solution | PSN | 7 |
| 1117394 | dextromethorphan hydrobromide 4 MG/ML / guaifenesin 60 MG/ML Oral Solution | SCD | 7 |
| 1117394 | dextromethorphan hydrobromide 20 MG / guaifenesin 300 MG per 5 ML Oral Solution | SY | 7 |
| Class | Version | Type | Effective |
|---|---|---|---|
| DEXTROMETHORPHAN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bf324df6-7127-7deb-def5-2681c136cd03 | Product name | 3 | 20250325 |
| 43a1ed49-eae2-4840-8075-cb4b33478540 | Product name | 1 | 20230425 |
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| 76633df9-0d59-4b88-03ed-21dee1b966f8 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69729-020-04 | 2024-04-02 | C162847 | 48780-1 | 1030e365-1e73-111a-e063-dadaa90a10e2 | Histiacil NF Pentrexicilina NF Brosolvan |
| 69729-020-04 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1e73-111a-e063-dadaa90a10e2 | Histiacil NF Pentrexicilina NF Brosolvan |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69729-020-04 | DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN | 118 mL in 1 BOTTLE | SYRUP | 118 | 7 | |
| 69729-040-04 | DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN | 118 mL in 1 BOTTLE | SYRUP | 118 | 7 | |
| 69729-062-04 | DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN | 118 mL in 1 BOTTLE | SYRUP | 118 | 7 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69729-020 | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP [OPMX LLC] | 7 | Current NDC, Legacy NDC, 1 package rows | 20250516_826c2f47-00a6-4060-a7ad-1ef26ccfddd1.zip |
| 69729-040 | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP [OPMX LLC] | 7 | Current NDC, Legacy NDC, 1 package rows | 20250516_826c2f47-00a6-4060-a7ad-1ef26ccfddd1.zip |
| 69729-062 | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP [OPMX LLC] | 7 | Current NDC, Legacy NDC, 1 package rows | 20250516_826c2f47-00a6-4060-a7ad-1ef26ccfddd1.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69729-062 | 69729-062-04 |
| 69729-040 | 69729-040-04 |
| 69729-020 | 69729-020-04 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | OPMX LLC | 826c2f47-00a6-4060-a7ad-1ef26ccfddd1 | 2025-05-15 | Warnings | 69729-062-04 69729-020-04 69729-040-04 69729-062 69729-040 69729-020 69729002004 69729004004 69729006204 352f8de3-8fe0-4098-e063-6294a90ace4d 826c2f47-00a6-4060-a7ad-1ef26ccfddd1 |
Adverse event summaries are temporarily unavailable. Other product information remains available.